Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod
There is always a lack of effective treatment for highly active refractory generalized myasthenia gravis (GMG). Recently, telitacicept combined with efgartigimod significantly reduces circulating B cells, plasma cells, and immunoglobulin G, which bring…